Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Defense was posted on June 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing

Closed
HT942626RE023Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 5 days
NAICS: 541714
New
Federal
Hypoxia Chamber Services
Solicitation # 80JSC026Q0008
NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 19 days
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 19 days

AI Contract Overview

Show more

The contract solicitation HT942626RE023, issued by the Defense Health Agency under the Department of Defense, seeks a Firm-Fixed Price award for research, development, and validation of field-expedient external proficiency testing procedures to detect pathogens in arthropods such as mosquitoes using non-infectious agents. The work is scoped under the title Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing and is governed by a Performance Work Statement and Quality Assurance Surveillance Plan, both attached to the solicitation. The contract has a 12-month period of performance from September 30, 2026, to September 29, 2027, with a kickoff meeting required within 15 calendar days of award. Deliverables include a draft and final written manual for safe external proficiency testing, a validation report documenting accuracy, precision, analytical sensitivity, and specificity, and a results package demonstrating statistically valid data from at least 60 samples. The solicitation is not a set-aside and utilizes NAICS code 541714 for biotechnology research and development. All work is classified as unclassified but involves handling of Controlled Unclassified Information, and the Government requires unlimited rights to all data and deliverables produced, with contractors prohibited from asserting limited or restricted rights without prior written approval. Proposals must be submitted electronically by June 16, 2026, to Benjamin Marcus at the designated email address, formatted in Microsoft Word, Excel, or searchable PDF with no zip files permitted. Offers must be organized into two volumes: Volume I, limited to 10 pages, detailing technical approach, expertise in external quality assurance, quality control measures, sourcing strategy, and schedule compliance; and Volume II, with no page limit, presenting unit and total prices for the single contract line item. Evaluation is based on pass/fail gates for Technical Capabilities, requiring at least an Acceptable rating, and Price Reasonableness, requiring a complete and reasonable total proposed price; awards will be made to the most advantageous offer without exchanges. Contractors must comply with multiple FAR and DFARS clauses including those on SAM maintenance, prohibition on inverted domestic corporations, electronic payment submissions via WAWF, and restrictions on covered defense telecommunications equipment. Payment instructions are tailored to WAWF with specific voucher types required based on line item structure, and the Contracting Officer’s Representative will oversee performance using the QASP, which also integrates compliance with anti-trafficking requirements. Offer

General Info

Research contract for vector-borne disease surveillance via proficiency testing, Defense Health Agency, Maryland.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

(7)

Combined Synopsis Solicitation HT942626RE0230002 Pacific Region Vector-borne Disease Surveillance R&D

PDFrfq

Combined Synopsis/Solicitation HT942626RE023 for Vector-borne Disease Surveillance R&D

PDFrfq

Pacific Region Force Health Protection Vector-borne Disease Agent Surveillance PWS

DOCXpws

Combined Synopsis Solicitation HT942626RE0230001 Pacific Region Vector-borne Disease Surveillance R&D

PDFrfq

QASP for Pacific Region Force Health Protection Vector-borne Disease Agent Surveillance

DOCXqasp

HT942626RE023 Questions and Answers for Vector-borne Disease Surveillance R&D

XLSXq-and-a

Amendment 0001 to Solicitation HT942626RE023

PDFamendment

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

2 updates
PhaseClosed
Posted

Combined Synopsis

Amendment 1

Contract was updated

Amendment 2

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeFORT DETRICK, MD, 21702, USA
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressFORT DETRICK, MD, 21702, USA
Contacts
Benjamin Marcus

Full Description

Show more

Please see the attached combined synopsis-solicitation, performance work statement (PWS), and quality assurance surveillence plan (QASP). 


Amendment 0001 includes one administrative chnage and contractor Q&A.


Amendment 0002 includes consolidated contractor Q&A under attachment HT942626RE023 Questions and Answers and updates the contract specialist phone number.


More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS